cis-platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma
- 1 February 1983
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 10 (2) , 100-103
- https://doi.org/10.1007/bf00446218
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)Cancer, 1981
- Epithelial Carcinoma of the Ovary: Current StrategiesAnnals of Internal Medicine, 1981
- Prospective study with HEXA-CAF combination in ovarian carcinomaCancer Chemotherapy and Pharmacology, 1981
- cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.1979
- Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.1979
- Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.1979
- The CHAD and HAD regimens in advanced ovarian cancer: combination chemotherapy including cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II).1979
- Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma.1979
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- COMBINATION CHEMOTHERAPY FOR OVARIAN CARCINOMA WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND CIS-DICHLORODIAMMINEPLATINUM(II) AFTER FAILURE OF INITIAL CHEMOTHERAPY1978